CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 50 enrolled
Drug / intervention
PRISMA 3T MRI scanner (Siemens Medical Solutions)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02888119
NCT02888119N/ACompleted

Imaging Biomarkers of Knee Osteoarthritis

NYU Langone Health·interventional·Posted Sep 2, 2016·Updated Dec 27, 2022

In Brief

A clinical study evaluating PRISMA 3T MRI scanner (Siemens Medical Solutions) for Osteoarthritis. Completed, enrolled 50 participants across 1 site.

Detailed Summary

This study aims to develop, evaluate and translate highly accelerated imaging sequences (each protocol under 5 minutes) for in-vivo knee Osteoarthritis applications on a standard clinical 3T scanner using novel compression sensing and parallel imaging strategies.The overarching objective of the study is to establish a non-invasive imaging biomarker based on the development of rapid relaxation mapping with compressed sensing (CS) that will be clinically useful for assessment of early Osteoarthritis. A total of 90 subjects including 30 patients with high risk of developing knee osteoarthritis (OA), 30 patients with mild OA and 30 healthy controls will be accrued.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOsteoarthritis
CountriesUnited States

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedSep 2, 2016
Enrollment StartJul 1, 2016
Primary CompletionDec 13, 2021
TodayJul 2, 2026
Enrollment to primary: 5.5 yearsPosted 9.8 years ago

Interventions

PRISMA 3T MRI scanner (Siemens Medical Solutions)device

A baseline MRI exam consisting of accelerated 3D-T1p, and T2, MRI will be performed. Longitudinal follow-up MRI exams (24 months) will be repeated on the same knee on all OA patients.